Skip to main content
. 2023 Jun 7;14:1175960. doi: 10.3389/fimmu.2023.1175960

Table 4.

PFS according to baseline characteristics.

No. of Patients (%) Median PFS (months) HR (95%CI)
Age group
 <65 years 27 (67.5%) 7.90 0.98 (0.94-1.03)
 ≥65 years 13 (32.5%) 10.30
Sex
 Female 1 (2.5%) Undefined Undefined
 Male 39 (97.5%) 8.60
Smoking status
Never smoked 3 (7.5%) 11.60 1.61 (0.80-3.24)
Current smoker 32 (80%) 6.80
Former smoker 5 (12.5%) 11.70
Disease stage
 III 9 (22.5%) 9.40 1.596 (0.66-3.89)
 IV 31 (77.5%) 7.90
ECOG score
 0 7 (17.5%) 7.40 1.041 (0.40-2.71)
 1 33 (82.5%) 8.70
Brain metastasis at enrollment
 YES 3 (7.5%) 6.67 2.66 (0.28-24.97)
 NO 37 (92.5%) 8.63
Liver metastases at enrollment
 YES 6 (15%) 6.70 1.69 (0.53-5.42)
 NO 34 (85%) 9.37